// App-Quantinova.ai

: RTHP-07. TRANSCRIPTION FACTOR NETWORKS OF OLIGODENDROGLIOMAS (IDH-MUTANT AND 1p/19q CODELETED) TREATED WITH ADJUVANT RADIOTHERAPY OR OBSERVATION INFORMS PROGNOSIS

Researchers

Presenter

  • Jonathan So

Principal Investigators

  • Fabio Moraes

  • Yasin Mamatjan

  • Kenneth Aldape

  • Gelareh Zadeh

Medical Centers

  • Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.

  • Princess Margaret Cancer Centre - University Health Network, University of Toronto, Princess Margaret Cancer Centre / MacFeeters-Hamilton Centre for Neuro-Oncology Research, Toronto, ON, Canada

  • MacFeeters-Hamilton Centre for Neuro-Oncology Research, Princess Margaret Cancer Center, Toronto, ON, Canada

  • Center for Cancer Research, National Cancer Institute, Bethesda, MD

  • Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Aryl hydrocarbon receptor nuclear translocator-like protein 1

  • CLOCK

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved